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Abstract  22 
Background: Identifying arrhythmogenic sites to improve ventricular tachycardia (VT) ablation 23 
outcomes remains unresolved. The re-entry vulnerability index (RVI) combines activation and 24 
repolarization timings to identify sites critical for re-entrant arrhythmia initiation without inducing VT.  25 
Objective: To provide the first assessment of RVI’s capability to identify VT sites of origin using high-26 
density contact mapping and comparison with other activation-repolarization markers of functional 27 
substrate.    28 
Methods: 18 VT ablation patients (16M, 72% ischemic) were studied. Unipolar electrograms were 29 
recorded during ventricular pacing and analysed off-line. Activation time (AT), activation-recovery 30 
interval (ARI), repolarization time (RT) were measured. Vulnerability to re-entry was mapped based 31 
on RVI and spatial distribution of AT, ARI and RT. The distance from sites identified as vulnerable to 32 
re-entry to the VT site of origin was measured, with distances <10 mm and >20 mm indicating accurate 33 
and inaccurate localization, respectively.  34 
Results: The origin of 18 VTs was identified (n=6 entrainment, n=12 pace-mapping). RVI maps included 35 
1012, 408—2098 (median, 1st—3rd quartiles) points/patient. RVI accurately localized 72.2% VT sites of 36 
origin, with median distance equal to 5.1, 3.2—10.1 mm. Inaccurate localization was significantly less 37 
frequent for RVI than AT (5.6% vs 33.3%, OR=0.12, P=0.035). Compared to RVI, distance to VT sites of 38 
origin was significantly larger for sites showing prolonged RT and ARI, and non-significantly larger for 39 
sites showing highest AT and ARI gradients.  40 
Conclusion: RVI identifies vulnerable regions closest to VT sites of origin. Activation-repolarization 41 
metrics may improve VT substrate delineation and inform novel ablation strategies. 42 
 43 
Keywords: Re-entry vulnerability index, activation time, repolarization time, ventricular tachycardia, 44 




Recurrence rates of ventricular tachycardia (VT) in structural heart disease remain sub-optimal at 50% 47 
on average for a first time catheter ablation highlighting the need for more effective ablation 48 
strategies 1. Although VT induction and activation/entrainment mapping is the preferred method to 49 
identify the circuit, this often cannot be performed due to instability of the VT itself or haemodynamic 50 
compromise 2. Substrate ablation strategies have been proposed and are based upon electrogram 51 
features related to signal morphology or local conduction parameters 3,4.  52 
Despite the fact that the earliest research in the field identified spatio-temporal repolarization 53 
dynamics as one of the fundamental factors modulating vulnerability to re-entry 5, current clinical 54 
practice relies almost exclusively on conduction-related parameters to identify target sites. A 55 
prerequisite for re-entry is unidirectional block whereby an activation wavefront blocks at a region of 56 
late repolarization where tissue is still refractory, circumvents the area of block through slow 57 
conducting pathways and re-enters the proximal region. The ability to re-enter the proximal region 58 
depends not only on the conduction delay around the blocked area but also on the timing of the 59 
returning wavefront relative to completion of repolarization and hence re-excitability in the proximal 60 
region 6. This is the basis of the re-entry vulnerability index (RVI)6,7, an activation-repolarization metric 61 
that provides a point-by-point quantification of the likelihood of re-entry and enables functional VT 62 
substrate delineation.  63 
Previous mechanistic studies 6–9 based on ex-vivo animal data and computational models have 64 
confirmed the link between RVI and sites of VT initiation. Preliminary observations on retrospective 65 
data utilising non-contact mapping technology in selective RV disorders have shown encouraging 66 
results 10. However, RVI’s potential as a clinical tool to localize critical sites for VT initiation has never 67 
been formally assessed using state of the art high-density mapping.  The aim of this study was to relate 68 
the vulnerable region delineated by RVI to the VT site of origin (VT-SoO) and compare RVI to other 69 




Concept and quantification of RVI 72 
The RVI concept is illustrated in Figure 1. Panel A illustrates the case of bidirectional block and no re-73 
entry: An activation wavefront (orange line) arrives at a region that is refractory and blocks (point P). 74 
The wavefront travels around the area of block (orange line) and arrives back at the distal side of the 75 
block (point D) which is still refractory and blocks in the reverse direction (bidirectional block). 76 
Bidirectional block occurs because repolarization time at point P is longer than activation time at point 77 
D. Panel B illustrates the case where re-entry occurs. The returning wavefront arrives back at the initial 78 
site of block (point D) when the region proximal to it has regained excitability. The returning wavefront 79 
is now able to propagate back to the proximal region and complete a re-entrant circuit. Re-entry 80 
occurs because repolarization time at point P is shorter than activation time at point D. The re-entry 81 
vulnerability index (RVI) is represented by the interval between activation time at the distal site D and 82 
repolarization at the proximal site P, i.e. RTP-ATD, shown as shaded areas in Figure 1. A shorter RVI 83 
(panel B) is more likely to be associated with re-entry than a longer RVI (panel A). 84 
  85 
Patients and procedures 86 
Patients with structural heart disease undergoing catheter ablation for VT were prospectively 87 
recruited at the Barts Heart Centre and St Thomas’s Hospital, London, UK. Patients gave informed 88 
consent for inclusion into VT mapping research approved by local REC. Cardiac mapping was 89 
performed either with CARTO (Pentaray and Decanav) or with EnSite Precision (HD Grid) (Table 1). The 90 
mapping data were included in the study if the VT-SoO was identified and a sufficiently dense 91 
substrate map was produced.  92 
Mapping was performed during ventricular pacing from the RV apex. If pacing was well tolerated, a 93 
train of 5 S1 paced beats was delivered followed by an S2 beat at a short coupling interval (Table 1) to 94 
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induce slow conduction necessary for RVI calculation 7. If continuous pacing was poorly tolerated, 95 
either a train of three short coupled beats were delivered or a single paced beat was delivered shortly 96 
after sensing the R-wave of a sinus beat. In one patient with severely impaired function, biventricular 97 
pacing was delivered at a normal rate (60 bpm). The pacing procedure was continuously repeated and 98 
data collected on the post-extra systolic beat using standard criteria to enable high-density sequential 99 
mapping  100 
In case of haemodynamically tolerated VTs, identification of VT-SoO was defined either by 101 
entrainment or by termination of VT during ablation. For unstable VTs, the VT-SoO was identified using 102 
pace mapping with an average correlation coefficient between the 12 lead ECG of VT and the paced 103 
beat ≥ 90% 11. If multiple sites for the same VT were identified with pace mapping, the site providing 104 
the highest correlation was retained.  105 
Ablation was delivered at the VT sites of origin and at other sites to achieve substrate modification 106 
using standard criteria 2 and was not based on RVI, which was computed off-line.  107 
 108 
Data Analysis 109 
Unipolar electrograms were recorded with band-pass filters set at 0.05-500 Hz and were exported 110 
along with anatomical data for bespoke off-line analysis in Matlab (Mathwork), which included 111 
stringent criteria for selecting only beats showing very similar activation/repolarization patterns (see 112 
Supplemental Methods). AT , RT and ARI were measured following standard definitions 12,13  (Figure 2) 113 
using automatic robust algorithms developed and tested during the course of previous studies 10,14–17. 114 
Markers were revised using bespoke graphical user interfaces and semi-automatic correction, which 115 
involved performing automatic annotation within manually adjusted windows of interest. Correction 116 
was limited to isolated outliers to reduce arbitrary annotation and ensure reproducibility.  117 
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Localization of sites vulnerable to re-entry 118 
The algorithm for RVI mapping operates as follow: For each cardiac site, neighbouring electrode sites 119 
are identified within a searching radius R=8 mm. The intervals between RT at a given site P and AT at 120 
neighbouring sites D, i.e. RTP-ATD, are measured.  The shortest of these intervals represent the RVI at 121 
site P. An RVI value was thereby obtained for each electrode site in the mapped area. This process is 122 
summarized in Figure 3, where an example is provided.  123 
For the sake of comparison, local gradients of AT, ARI and RT, which provide a quantification of local 124 
activation and repolarization heterogeneity, were also computed (Figure 3).          125 
The distance between the VT-SoO and the nearest of the following sites was measured in order to 126 
assess the capability of localizing critical sites for VT initiation:  127 
• Sites showing the lowest RVI, i.e. RVI < 5th percentile of RVI values. RVI ≥ 300 ms were excluded 128 
from those considered as vulnerable to re-entry even if within the lowest 5%.   129 
• Sites showing the largest AT, RT and ARI gradients, i.e. sites for which local gradients were > 130 
the 95th percentile of their distributions.  131 
• Sites showing the longest AT, i.e. AT > 95th percentile of AT values. 132 
• Sites showing the longest RT and ARI, i.e. sites for which RT and ARI were > the 95th percentile 133 
of their distributions. 134 
• Sites showing the shortest RT and ARI, i.e. sites for which RT and ARI were < the 5th percentile 135 
of their distributions. 136 
 137 
Statistical Analysis 138 
Data are reported as median, 1st—3rd quartiles. The Wilcoxon signed-rank test was used for comparing 139 
distances between VT-SoO and vulnerable sites identified by different markers with P<0.05 indicating 140 




In total, 18 patients were included in the study. Baseline characteristics are reported in Table 1. 143 
Patients were aged 65, 52—70 years (median, 1st—3rd) and 16 were male. Pathologies included 144 
ischaemic heart disease (n=14, 78%) and ARVC (n=4, 22%). The cycle length of the beat preceding the 145 
mapped beat was 360, 360—398 ms and electro-anatomical maps for RVI calculation included 1012, 146 
408—2098 unipolar electrograms (Table 1). Some patient presented more than 1 VT morphology at 147 
the time of the procedure, but in all cases the site of origin of only one VT was identified and confirmed 148 
by either entrainment (n=6) or pace mapping (n=12) (Table 1). Other VTs were not mapped either 149 
because they were thought not to be clinical or because a substrate ablation approach was preferred. 150 
This was often the case, as VT was unstable in two third of patients.  151 
Acute VT-inducibility was tested at the end of the procedure in 12 patients (67%), while considered 152 
inappropriate in the other 6 (33%) owing to haemodynamic compromise. None of the mapped VTs 153 
was inducible at the end of the procedure, while in 2 (16%) patients a different VT morphology was 154 
induced.    155 
During the follow-up (16.2, 7.1-20.3 months, median, minimum-maximum), 50% of patients (75% of 156 
ARVC and 43% of ischemic patients) suffered a recurrence, defined as any therapy from the 157 
implantable device, including anti-tachycardia pacing, heart transplant or death from any cause.   158 
 159 
Assessment of RVI in relation to VT sites of origin  160 
Figures 4A-C shows RVI maps in a patient for which the VT-SoO was identified by entrainment. The 161 
sites of lowest RVI are clustered around the VT-SoO, with the closest one being 3.1 mm away from it. 162 
Unipolar electrograms from electrode sites with large and low RVI are shown in Figure 4D-E. Figure 163 
5A-C shows examples from another patient, where the VT-SoO was identified by pace mapping. In this 164 
case, the distance between lowest RVI sites and the VT-SoO was 3.4 mm. Some of the lowest RVI sites 165 
are distant from the VT-SoO, which is expected as these may be related to a different re-entrant circuit 166 
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from that identified during the procedure. Unipolar electrogams are shown in Figure 5D-E, with low 167 
amplitude fractionated signals recorded at site of low RVI (panel E) close to the VT-SoO. 168 
Considering all 18 VTs, the distance between sites of lowest RVI and the VT-SoO was 5.1, 3.2—10.1 169 
mm (median, 1st – 3rd quartile) (Table 1). This was not different in ischaemic and ARVC patients (4.9, 170 
3.1-10.7 mm vs 5.2, 2.6-11.6 mm, P=0.95) or in VTs whose site of origin was identified using pace 171 
mapping vs entrainment (5.1, 4.1-9.5 mm vs 4.0, 2.5-17.9 mm, P=0.82).  172 
Similar results were obtained using searching radius R = {7, 8, 9, 10} mm, but for smaller search radii 173 
the distance between the vulnerable region and the VT-SoO increased (Supplementary Figure 1).    174 
 175 
Comparison between RVI and other markers in relation to VT sites of origin  176 
The distance between the VT-SoO and lowest RVI sites was shorter than that for any other activation-177 
repolarization marker (Figure 6). Pair-wise comparisons showed that the distance to the VT-SoO was 178 
significantly shorter for lowest RVI sites than for sites showing longest RT (P=0.020), longest ARI 179 
(P=0.004) and shortest RT (P=0.042). Despite showing the lowest median value as well as lowest 180 
standard deviation across all mapped VTs, distance to the VT-SoO from lowest RVI sites was not 181 
significantly smaller than distance to the VT-SoO from sites showing largest local gradients of AT (GAT, 182 
P=0.17), ARI (GARI, P=0.49), RT (GRT, P=0.11), or from sites showing lowest ARI (0.68) and largest AT 183 
(P=0.13) (Figure 6).  184 
The identification of VT-SoO was considered accurate if the distance to the VT-SoO was <10 mm and 185 
inaccurate if >20 mm. RVI showed the highest accuracy, with 13 VT-SoO out of 18 located within 10 186 
mm to lowest RVI sites (72.2%, Figure 7A) as well as the lowest inaccuracy rate, with only 1 VT-SoO 187 
located at more than 20 mm from lowest RVI sites (5.6%, Figure 7B). Inaccurate identification of VT-188 
SoO was significantly less likely to occur for lowest RVI than for longest AT and longest ARI (odd ratio 189 
equal to 0.12, P=0.035, Chi-squared test, for both markers, Figure 7B).  190 
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Interaction between RVI and other markers  191 
RVI showed positive correlation with ARI, cc = 0.71, 0.59—0.76, and RT, cc = 0.52, 0.23—0.72, and a 192 
weaker inverse correlation with AT, cc = -0.26, -0.45— -0.07, GAT, cc = -0.25,-0.47— -0.12 and GARI, cc 193 
= -0.26, -0.44—0.09 (Supplementary Figure 2A).   194 
Sites with lowest RVI partially overlapped with those showing shortest RT and ARI, with overlap equal 195 
to 35%, 23—42% and 24%, 12—44%, respectively (Supplementary Figure 2B). Only 5%, 0%—16% of 196 
sites with lowest RVI were also identified as vulnerable owing to longest AT. This increased to 13%, 197 
0%—21% when considering as overlapping sites situated at a distance ≤ 2 mm. About 15% of sites 198 
showing lowest RVI also showed largest gradients of AT or ARI. This suggests that RVI captures 199 
electrophysiological vulnerability independently from standard activation-repolarization markers. 200 
 201 
Discussion 202 
This is the first study to use state of the art mapping technology to comprehensively evaluate the RVI 203 
and alternative activation-repolarization markers in delineating the sites critical for VT establishment. 204 
The main results are: (1) RVI identifies vulnerable regions that were within 10 mm of VT-SO  in 72.2% 205 
of VTs and >20 mm away in only 5.6% of VTs, with the closest vulnerable site located 5.1, 3.2—10.1 206 
mm from the VT-SoO. (2) Inaccurate VT-SoO identification was significantly less frequent for lowest 207 
RVI than for longest AT and longest ARI. (3) Lowest RVI identifies vulnerable regions independent of 208 
other activation and repolarization markers and it incorporates information from both local AT and 209 
ARI gradients, which identified critical regions at a (non-significantly) larger distance than lowest RVI. 210 
RVI is based upon a conceptual model of the critical relationship between activation and repolarization 211 
restitution properties, which was formerly defined by Coronel and colleagues in an elegant animal 212 
study 6. That study demonstrated that the critical parameter to differentiate block from the initiation 213 
of re-entrant arrhythmia was the interval between the proximal RT of the premature beat and the 214 
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arrival time of the premature wave at the distal side of the line of block. This represents the foundation 215 
of the RVI algorithm, first implemented by Taggart and colleagues in a mechanistic proof-of-principle 216 
study 7. Results from retrospective analysis of non-contact mapping data in selective RV disorders 10 217 
and computational studies 8,9  have provided support to the validity of the RVI concept. This study has 218 
assessed for the first time the RVI as a potential clinical tool to identify critical targets for ablation by 219 
utilising state of the art mapping technology in both RV and LV pathologies and comparing it to other 220 
activation-repolarization metrics of functional substrate. The results suggest that RVI could represent 221 
a useful metric to inform novel substrate ablation strategies.  222 
While other studies have focused on improving the delineation of the arrhythmogenic substrate with 223 
late potentials 18,19, metrics related to slow conduction, visualization of potential  diastolic pathway 224 
and  characterization of channels using  imaging 2,20, this study demonstrates that repolarization is 225 
critical for the identification of VT-SoO.  226 
RVI performed similarly to, but independently of, local gradients of activation, an established marker 227 
of arrhythmia susceptibility 21, which is embedded in the RVI concept. A moderate correlation between 228 
RVI and local activation and repolarization gradients confirms the theoretical observation that RVI 229 
integrates information from both activation and repolarization dynamics.  230 
Current performance and future developments   231 
Despite its solid theoretical underpinning, RVI was not significantly superior to other markers in the 232 
identification of the VT-SoO. This may be partially due to lack of statistical power (n=18) and both 233 
procedural and technological limitations. A critical aspect of RVI is the pacing protocol, with both cycle 234 
length and pacing site potentially affecting RVI maps 8. The importance of stimulating the tissue at a 235 
coupling interval short enough to engage conduction velocity restitution to unmask 236 
electrophysiological vulnerability is well recognised 19. It may be possible that a more aggressive S1S2 237 
pacing protocol could have provided more precise localisation but at the risk of haemodynamic 238 
compromise and VT induction in these vulnerable patients. The pacing site affects both voltage 22 and 239 
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activation-repolarization properties 23 and pacing from multiple sites may improve RVI delineation of 240 
the arrhythmogenic substrate 8. This was not feasible due to time constraints during the procedure.       241 
Importantly, in structurally abnormal hearts, multiple pathways may support different VTs, some of 242 
which may not be revealed during the procedure. This limits the extent by which any metric 243 
theoretically related to sites susceptible to re-entry can be validated using information from the VTs 244 
mapped during the procedure.  Validation by prospective studies using ablation to target all low RVI 245 
sites will be required in randomised controlled trials to test this physiological mapping approach 246 
versus current VT ablation strategies to determine VT recurrence, hospitalisations and mortality.  247 
Limitations 248 
Although bespoke software solutions were implemented to analyse only beats with the same 249 
activation-repolarization sequence and semi-automatic correction was kept to a minimum to ensure 250 
reproducibility, repolarization variability during sequential mapping and the challenge of measuring 251 
activation/repolarization markers in diseased myocardium may have affected the results. Ultra-fast 252 
non-contact mapping providing AT and RT within one single beat may represent a possible solution 24.   253 
The identification of VT-SoO with pacing manoeuvres presents limitations inherent to electro-254 
anatomical mapping. Pace-mapping is a standard approach to identify the exit site of unstable VTs 11, 255 
but its accuracy can be affected by area of capture and functional block only present in VT. A previous 256 
study has reported 82% sensitivity and 87% specificity in identifying the exit region by pace mapping 257 
with a 82% morphology match 11. Our cut-off value of 90% morphology match should provide slightly 258 
higher specificity. Although none of the mapped VTs were inducible after ablation, acute VT induction 259 
could not be consistently tested as procedural end-point owing to hemodynamic compromise in 6 260 
patients. The recurrence rate was 50% after a median follow-up of 16 months, which is in line with 261 
other studies 1. This is likely due to limitations of current ablation strategies in complex patients with 262 
haemodynamic compromise and presenting multiple potential vulnerable sites for VT development 263 
most of which are concealed at the time of the procedure and cannot be localized with entrainment, 264 
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pace-mapping or standard substrate mapping.   This study did not set out to prospectively ablate low 265 
RVI sites, which will be the subject of future studies to assess whether this influences outcomes. 266 
Conclusions     267 
These data show that RVI identifies vulnerable regions that closely correlate with the VT site of origin 268 
and suggest that activation-repolarization metrics may improve the delineation of the arrhythmogenic 269 
substrate and enable optimal substrate based ablation without the risks of compromising the patient 270 
with multiple VT inductions.  271 
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1 M 69 IHD PM CARTO Pentaray 500 S1S1 4190 8.3 
2 F 34 ARVC ENT CARTO Pentaray 460 S1S1 2256 17.9 
3 M 71 IHD PM CARTO Pentaray 360 S1S2 2560 4.9 
4 F 52 ARVC PM CARTO Pentaray 360 S1S1 1312 5.2 
5 M 79 IHD ENT CARTO Pentaray 380 S1S2 260 4.8 
6 M 55 IHD PM CARTO Pentaray 360 S1S2 1625 8.2 
7 M 70 IHD PM CARTO Pentaray 360 S1S2 370 16.5 
8 M 73 ARVC PM CARTO Pentaray 360 S1S2 328 5.2 
9 M 22 ARVC PM CARTO Decanav 1000 S1S1BV 4325 0.0 
10 M 65 IHD ENT Precision HD-Grid 360 SE 1341 33.9 
11 M 68 IHD PM Precision HD-Grid 360 SE 1304 13.8 
12 M 50 IHD PM Precision HD-Grid 360 SE 4328 10.7 
13 M 61 IHD ENT Precision HD-Grid 325 SE 719 1.9 
14 M 65 IHD PM Precision HD-Grid 360 S1S2 356 3.4 
15 M 77 IHD PM Precision HD-Grid 400 SE 389 5.0 
16 M 60 IHD PM Precision HD-Grid 390 SE 466 1.7 
17 M 52 IHD ENT Precision HD-Grid 360 SE 511 3.1 






















































































Table 1: Patient’s information. IHD: ischemic heart disease; ARVC: Arrythmogenic Right Ventricular 350 
Cardiomyopathy. Pacing manoeuvres to determine the VT site of origin, VT-SoO, were either 351 
entrainment (ENT) or pace mapping (PM). Electro-anatomical mapping systems were CARTO or Ensite 352 
Precision. Pacing types were S1S1, S1S2 or sensed-extras (SE). S1S1BV denotes bi-ventricular pacing. 353 
Points on Map is the number of unipolar electrograms per map. Dist to VT-SoO is the distance between 354 





Figure 1: Theoretical model underpinning the re-entry vulnerability index (RVI). See text. Similar 358 






Figure 2: Computation of spatial activation-repolarization metrics. A: Stylised action 363 
potentials and unipolar electrograms showing standard measurements of activation (AT) and 364 
repolarization (RT) times. B: Conceptual model for RVI measurement (left) and RVI 365 
measurements using recorded unipolar electrograms (right).  366 
   367 
 368 




Figure 3: Computation of RVI and spatial activation-repolarization metrics. Left: The red dot 371 
represents a cardiac site P for which RVI is measured. Black dots represent neighbouring cardiac sites 372 
within a searching radius R. As shown in the example in the box, RVI is the shortest interval between 373 
AT at neighbouring sites and RT at site P, RTP-ATD. The formula for RVI and local gradients 374 
measurement are reported on the right. Local gradients of ARI and RT are measured in the same way. 375 
The criteria for identifying vulnerable sites to re-entry are given in the bottom-right panel. 376 
 377 




Figure 4: Example of RVI identifying vulnerable sites close to an entrained VT. A: Anatomical map 380 
showing the VT site of origin (VT-SoO) as a white dot. B: RVI map where each dot represents a cardiac 381 
site and RVI is colour-coded. C: map showing sites showing the lowest 5% of RVI values. D-E: Unipolar 382 
electrograms from an electrode site showing high (D) and low (E) RVI (red line) and from neighbouring 383 
electrode sites (grey).  Red and grey circles represent RT at the site of RVI measurement, RTP, and AT 384 





Figure 5: Example of RVI identifying vulnerable sites close to a pace-mapped VT. See Figure 4’s 388 
legend for details. 389 
 390 




Figure 6: Distance to VT site of origin. Distance between the VT site of origin (VT-SoO) and nearest 393 
vulnerable sites identified by lowest RVI (RVIMIN), largest gradients of AT (GAT,MAX), largest gradients of 394 
RT (GRT,MAX), largest gradients of ARI (GARI,MAX), longest AT (ATMAX), shortest RT (RTMIN), longest RT 395 
(RTMAX), shortest ARI (ARIMIN) and longest ARI (ARIMAX). Markers indicate the median of minimum 396 
distances and bars span the 1st—3rd quartile interval (across n=18 VTs). *: P<0.05 with respect to 397 
RVIMIN..  398 
 399 




Figure 7: Accuracy of VT sites of origin localization.Proportion of VTs for which the distance between 402 
VT-SoO and the vulnerable sites was <10 mm (A, accurate localization of VT-SoO). >20 mm (B, 403 
inaccurate localization of VT-SoO). * : P<0.05 with respect to RVIMIN.  404 
 405 
